Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "RI"

10747 News Found

HealthFab raises Rs 20 crore in Series A funding from Atomic Capital
Startup | May 04, 2026

HealthFab raises Rs 20 crore in Series A funding from Atomic Capital

Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions


Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety
Hospitals | May 04, 2026

Sankara Eye Hospital hosts ‘CSSD 360’ workshop on sterilisation and patient safety

Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings


C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities
Biopharma | May 04, 2026

C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities

India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide


HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur
Hospitals | May 04, 2026

HOSMAC enables first phase of 1,200-bed Tapanbhai Patel Memorial Hospital in Shirpur

Hospital project inaugurated by Devendra Fadnavis aims to strengthen healthcare access across North Maharashtra and nearby regions


Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive
News | May 04, 2026

Allergan Aesthetics ties referrals to skin cancer awareness month with $100,000 donation drive

The initiative pairs consumer engagement with a public health message about prevention and early detection


Bristol Myers Squibb begins 2026 with growth momentum
News | May 04, 2026

Bristol Myers Squibb begins 2026 with growth momentum

The company’s Growth Portfolio delivered $6.2 billion in revenue


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Merck posts mixed Q1 2026 results as blockbuster drugs drive growth
News | May 02, 2026

Merck posts mixed Q1 2026 results as blockbuster drugs drive growth

But acquisition charges drag earnings into loss


Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi
interviews | May 01, 2026

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules


Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
People | May 01, 2026

Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO

Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion